Visfatin

Study of the correlation between growth hormone deficiency and serum leptin, adiponectin, and visfatin levels in adults

Z. - P. Li, Zhang, M., Gao, J., Zhou, G. - Y., Li, S. - Q., and An, Z. - M., Study of the correlation between growth hormone deficiency and serum leptin, adiponectin, and visfatin levels in adults, vol. 13, pp. 4050-4056, 2014.

We aimed to determine the significance and changes in leptin, adiponectin (ADP), and visfatin levels in adults with growth hormone deficiency (GHD). Forty adults (19 men, 21 women) who had been diagnosed with GHD comprised the observation group, while 36 healthy adults (18 men, 18 women) were used as the control group. Fasting venous blood was collected to detect leptin, ADP, and visfatin levels. There was no statistically significant difference (P > 0.05) between the GHD group and the control group in terms of gender ratio, age, and body mass index.

An elevated plasma level of visfatin increases the risk of myocardial infarction

Y. Yang, Li, Z., Tao, H. F., Qi, X. Y., Wang, W. L., Yang, L., Wang, H., and Xu, P., An elevated plasma level of visfatin increases the risk of myocardial infarction, vol. 13, pp. 8586-8595, 2014.

Visfatin, an adipocytokine involved in metabolic and immune disorders, plays an important role in the etiology of cardiovascular disease. Recent evidence has shown that an elevated plasma level of visfatin may increase the risk of myocardial infarction (MI), but individual published studies have shown inconclusive results. This study aimed to obtain a more precise estimate of the association between the plasma visfatin level and MI risk through a detailed meta-analysis of studies published in peer-reviewed journals.

Subscribe to Visfatin